Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020594
Filing Date
2021-08-18
Accepted
2021-08-18 17:31:49
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 778274
2 ex31-1.htm EX-31.1 19548
3 ex32-1.htm EX-32.1 7628
4 GRAPHIC image_001.jpg GRAPHIC 4376
  Complete submission text file 0001493152-21-020594.txt   3955907

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gcan-20210630.xsd EX-101.SCH 32740
6 XBRL CALCULATION FILE gcan-20210630_cal.xml EX-101.CAL 40142
7 XBRL DEFINITION FILE gcan-20210630_def.xml EX-101.DEF 164592
8 XBRL LABEL FILE gcan-20210630_lab.xml EX-101.LAB 260320
9 XBRL PRESENTATION FILE gcan-20210630_pre.xml EX-101.PRE 227050
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 497235
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56027 | Film No.: 211187605
SIC: 2834 Pharmaceutical Preparations